Rankings
▼
Calendar
CRDF
Cardiff Oncology, Inc.
$133M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$68,000
Gross Profit
-$519,000
-763.2% margin
Operating Income
-$10M
-14385.3% margin
Net Income
-$9M
-12570.6% margin
EPS (Diluted)
$-20.04
QoQ Revenue Growth
-23.7%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$44M
Total Liabilities
$24M
Stockholders' Equity
$20M
Cash & Equivalents
$38M
← FY 2016
All Quarters
Q1 2017 →
CRDF Q4 2016 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena